BPC-157 10mg

Research applications

• Rodent models of tendon and ligament injury repair
• Gastrointestinal mucosal protection and healing research
• Angiogenesis and vascular signalling studies
• Cytoprotective pathway research in animal models

What the literature reports on BPC-157

BPC-157 derives its designation from Body Protection Compound, reflecting its origin as a fragment of a gastric-protective protein. As a synthetic 15-residue peptide, it is studied as a stable research tool rather than a naturally occurring isolate, and its pharmacology has been characterised primarily in rodent injury models.

Tissue repair research

A substantial portion of the BPC-157 literature examines its effects in rodent models of tendon, ligament and muscle injury, with studies reporting accelerated markers of healing and altered expression of growth factors implicated in tissue repair, including vascular endothelial growth factor (VEGF) signalling.

Gastrointestinal research

Reflecting its origin in gastric-protective research, BPC-157 has been studied in rodent models of gastrointestinal mucosal injury, with reported effects on healing markers in models of gastric ulceration and inflammatory bowel injury. This research thread connects BPC-157 to a broader literature on gut mucosal protective mechanisms.

Angiogenesis and signalling research

Multiple studies have reported that BPC-157 influences angiogenic signalling pathways, including modulation of VEGF receptor expression, and researchers have used this as a proposed mechanism connecting the peptide's reported effects across different tissue-repair models. This mechanistic research remains an active area of study across independent laboratories.

Comparative tissue-repair peptide research

BPC-157 is frequently studied alongside other tissue-repair-focused peptides such as TB-500, with combination and comparative research designs used to examine whether the two peptides, which are reported to act through different proposed mechanisms (angiogenic signalling versus actin-binding cytoskeletal regulation), produce additive effects in shared tissue-injury models.

Nervous system research

A growing body of research has extended BPC-157 study into models of peripheral nerve injury, examining markers of nerve regeneration and functional recovery following administration in rodent models, a research direction that connects BPC-157's tissue-repair pharmacology to neuroregeneration research more broadly.

Laboratory handling

BPC-157 should be stored as lyophilised powder at -20°C, protected from light and moisture, until reconstitution. Reconstitution follows standard peptide practice: diluent introduced slowly along the vial wall, followed by gentle mixing.

• Lyophilised powder: store at -20°C, protected from light, until reconstitution.
• Reconstitution: introduce diluent slowly along the vial wall; mix gently, do not shake.
• Post-reconstitution: 2-8°C for short-term laboratory use; avoid repeated freeze-thaw cycles.
• Each batch ships with a certificate of analysis confirming ≥99% purity by HPLC and identity by mass spectrometry.

See the peptide reconstitution and storage guide for a full protocol reference. This product is intended for laboratory research use only.